Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Clients save Millions in Drug Spend through the use of Innovative Pharmacy Analytics for Hospitals and Health Systems | ||
By: Nasdaq / GlobeNewswire - 22 Oct 2018 | Back to overview list |
|
Comprehensive Pharmacy Services RxClinical Analytics 2.0 is a Gamechanger for Managing Drug Hyperinflation and Clinical Performance MEMPHIS, Tenn., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Comprehensive Pharmacy Services (CPS) announced today the release of its innovative second generation pharmacy analytics tool – RxClinical Analytics 2.0 (RCA 2.0) – that targets reducing drug cost for hospitals and health systems while sustaining and improving clinical quality. In the era of value-based care and hyperinflated drug costs negatively impacting hospital and health systems margins, RCA 2.0 is a proven tool that enables improved clinical care while lowering drug costs. To date, the RCA platform has delivered CPS clients millions of dollars in drug savings while standardizing care and elevating clinical results. By combining data analytics with clinical documentation in a seamless view, the CPS RCA 2.0 application evaluates over 300 CPS proprietary clinical initiatives against the hospital’s drug purchases. Once target medications are found, the comparative drug therapy is identified that improves clinical quality, and/or drives down cost, and typically accomplishes both. Once all purchases have been evaluated, RCA 2.0 provides a prioritized listing of what protocols or initiatives have the greatest opportunity for improvement. In addition, the proprietary CPS RCA 2.0 aligns and recommends peer reviewed documents and reference materials within CPS’ curated proprietary clinical content database, RxIntelnet. CPS clinicians review, maintain and update the database, which now includes over 5,000 content pieces, on a regular basis. The content database includes assessment tools, clinical publications, and information critical to pharmacists. This material is searchable and designed intuitively so pharmacists can easily locate and link to the right information. CPS RCA 2.0 provides links to the clinical support documentation for each recommended protocol. The pharmacist is also able to take the RCA 2.0 output to P&T comittees or hospital administration in order to make the change across the hospital or health system. The information generated from the RCA 2.0 upgrade allows CPS client pharmacists to get a full picture of the financial and clinical aspects of the therapy conversion in one document that facilitates conversations with hospital stakeholders across the continuum of care. This enables care teams to capture more savings because the pharmacist no longer needs to extensively research the alternate therapy and pull all of that information together. RCA 2.0 provides new differentiated capabilities to the marketplace for hospital and health system pharmacies that include:
“By constantly surveilling medication costs that cut into a hospital’s already thin bottom line and identifying clinical alternatives, RCA 2.0 is reducing costs for our hospital and health system clients,” said Greg Bedenkop, PharmD, Division VP for Clinical Analytics at CPS. “Combined with the supporting resource documentation and monitoring success of clinical conversion efforts at the site means a win-win for every stakeholder across the continuum of care.” To learn more about the CPS RCA 2.0 application, email: contactus@cpspharm.com or call: 800.968.6962. About Comprehensive Pharmacy Services CONTACT: Rod Recor |
||
|
||
Copyright 2018 Nasdaq / GlobeNewswire | Back to overview list |